Clinical Course of Korean Crohn's Disease Cohort
Clinical Course of Crohn's Disease: a Prospective Multicenter Long-term Follow-up Study in Korea
1 other identifier
observational
2,000
1 country
9
Brief Summary
In the past decade, the incidence and prevalence of CD (Crohn's disease) has continued to increase in Korea. Previous studies have indicated that Asian IBD (inflammatory bowel disease) patients differ from those of Western patients with regard to the genetic susceptibility and some clinical features. However, the available published data from retrospective studies in Korea were largely incomplete. The investigators aim of the study is a set-up of Korean cohort for CD, and thereby to assess the clinical course of Korean CD patients through a prospective multicenter long-term follow-up study. Secondary aims of this study are as follows: (1) to evaluate the efficacy, tolerability, and predictors to response to anti-TNF therapy for CD, (2) to identify the risk factors for postoperative recurrence on the basis of information obtained at initial diagnosis, and (3) to evaluate genotype-phenotype correlation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2012
Longer than P75 for all trials
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 12, 2012
CompletedFirst Posted
Study publicly available on registry
March 14, 2012
CompletedStudy Start
First participant enrolled
December 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedOctober 26, 2016
October 1, 2016
6 years
March 12, 2012
October 25, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To explore natural course of Crohn's disease and to identify prognostic factors for poor disease outcome in Korean patients with Crohn's disease
10 years
Study Arms (1)
Crohn's disease
Korean patients diagnosed with Crohn's disease
Interventions
No intervention was administered to the participants specifically for the purpose this study. Participant could be on any drug therapy.
Eligibility Criteria
About 2000 patients diagnosed with Crohn's disease in the period of January 2009 to December 2018 in multiple hospitals in Korea.
You may qualify if:
- Patients over the age of 16
- Informed consent
- Patients who had a definitive diagnosis of Crohn's disease (documented by the standard clinical, radiographic, endoscopic, and histopathologic criteria)
- be capable of understanding the study and replying to the questionnaires
You may not qualify if:
- Any condition which, in the opinion of the Investigator, places the patient at unacceptable risk if he/she were to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kyunghee University Medical Centerlead
- Asan Medical Centercollaborator
- Hanyang Universitycollaborator
- Seoul National Universitycollaborator
- Severance Hospitalcollaborator
- Samsung Medical Centercollaborator
- Chung-Ang University Hosptial, Chung-Ang University College of Medicinecollaborator
- Kyung Hee University Hospital at Gangdongcollaborator
- Kangbuk Samsung Hospitalcollaborator
- Konyang University Hospitalcollaborator
- Korea University Anam Hospitalcollaborator
- Korea Universitycollaborator
- Eulji General Hospitalcollaborator
- Eulji Universitycollaborator
- SMG-SNU Boramae Medical Centercollaborator
- Pusan National University Hospitalcollaborator
- Inje Universitycollaborator
- Soonchunhyang University Hospitalcollaborator
- Songdo hospitalcollaborator
- Yeungnam University Hospitalcollaborator
- Wonkwang Universitycollaborator
- Wonju Severance Christian Hospitalcollaborator
- Ewha Womans Universitycollaborator
- Chonnam National University Hospitalcollaborator
- Jeju National University Hospitalcollaborator
- Chuncheon Sacred Heart Hospitalcollaborator
- Hangang Sacred Heart Hospitalcollaborator
- Dongtan Sacred Heart Hospitalcollaborator
- Chungbuk National University Hospitalcollaborator
- The Catholic University of Koreacollaborator
Study Sites (9)
Hanyang University Guri Hospital
Guri-si, South Korea
Kyunghee University Medical Center
Seoul, 180-702, South Korea
Asan Medical Center
Seoul, South Korea
Chung-Ang University
Seoul, South Korea
Inje University
Seoul, South Korea
Samsung Medical Center
Seoul, South Korea
Seoul National University SMG-SNU Boramae Medical Center
Seoul, South Korea
The Catholic University of Korea St. Vincent Hospital
Seoul, South Korea
Yonsei University; Severance Hospital
Seoul, South Korea
Related Publications (3)
Ye BD, Yang SK, Cho YK, Park SH, Yang DH, Yoon SM, Kim KJ, Byeon JS, Myung SJ, Yu CS, Kim JH. Clinical features and long-term prognosis of Crohn's disease in Korea. Scand J Gastroenterol. 2010 Oct;45(10):1178-85. doi: 10.3109/00365521.2010.497936.
PMID: 20560811BACKGROUNDKim ES, Kim WH. Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics. Gut Liver. 2010 Mar;4(1):1-14. doi: 10.5009/gnl.2010.4.1.1. Epub 2010 Mar 25.
PMID: 20479907BACKGROUNDYe BD, Jang BI, Jeen YT, Lee KM, Kim JS, Yang SK; IBD Study Group of the Korean Association of the Study of Intestinal Diseases. [Diagnostic guideline of Crohn's disease]. Korean J Gastroenterol. 2009 Mar;53(3):161-76. Korean.
PMID: 19835218BACKGROUND
Biospecimen
Whole blood, DNA, and serum will be retained for central biobank
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Joo Sung Kim, MD, PhD
Seoul National University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 12, 2012
First Posted
March 14, 2012
Study Start
December 1, 2012
Primary Completion
December 1, 2018
Study Completion
December 1, 2019
Last Updated
October 26, 2016
Record last verified: 2016-10
Data Sharing
- IPD Sharing
- Will not share